Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
European college of neuropsychopharmacology network on the prevention of mental disorders and mental health promotion (ECNP PMD-MHP).
Fusar-Poli P, Bauer M, Borgwardt S, Bechdolf A, Correll CU, Do KQ, Domschke K, Galderisi S, Kessing LV, Koutsouleris N, Krebs MO, Lennox B, McGuire P, Meyer-Lindenberg A, Millan MJ, Nieman D, Pfennig A, Sand M, Whenert A, van Amelsvoort T, Arango C. Fusar-Poli P, et al. Among authors: galderisi s. Eur Neuropsychopharmacol. 2019 Dec;29(12):1301-1311. doi: 10.1016/j.euroneuro.2019.09.006. Epub 2019 Oct 9. Eur Neuropsychopharmacol. 2019. PMID: 31606303 Free article. Review.
Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research.
Dazzan P, Arango C, Fleischacker W, Galderisi S, Glenthøj B, Leucht S, Meyer-Lindenberg A, Kahn R, Rujescu D, Sommer I, Winter I, McGuire P. Dazzan P, et al. Among authors: galderisi s. Schizophr Bull. 2015 May;41(3):574-83. doi: 10.1093/schbul/sbv024. Epub 2015 Mar 23. Schizophr Bull. 2015. PMID: 25800248 Free PMC article. Review.
Deconstructing vulnerability for psychosis: Meta-analysis of environmental risk factors for psychosis in subjects at ultra high-risk.
Fusar-Poli P, Tantardini M, De Simone S, Ramella-Cravaro V, Oliver D, Kingdon J, Kotlicka-Antczak M, Valmaggia L, Lee J, Millan MJ, Galderisi S, Balottin U, Ricca V, McGuire P. Fusar-Poli P, et al. Among authors: galderisi s. Eur Psychiatry. 2017 Feb;40:65-75. doi: 10.1016/j.eurpsy.2016.09.003. Epub 2016 Dec 16. Eur Psychiatry. 2017. PMID: 27992836 Free article. Review.
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study.
Kahn RS, Winter van Rossum I, Leucht S, McGuire P, Lewis SW, Leboyer M, Arango C, Dazzan P, Drake R, Heres S, Díaz-Caneja CM, Rujescu D, Weiser M, Galderisi S, Glenthøj B, Eijkemans MJC, Fleischhacker WW, Kapur S, Sommer IE; OPTiMiSE study group. Kahn RS, et al. Among authors: galderisi s. Lancet Psychiatry. 2018 Oct;5(10):797-807. doi: 10.1016/S2215-0366(18)30252-9. Epub 2018 Aug 13. Lancet Psychiatry. 2018. PMID: 30115598 Free article. Clinical Trial.
A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale.
Mucci A, Vignapiano A, Bitter I, Austin SF, Delouche C, Dollfus S, Erfurth A, Fleischhacker WW, Giordano GM, Gladyshev I, Glenthøj B, Gütter K, Hofer A, Hubeňák J, Kaiser S, Libiger J, Melle I, Nielsen MØ, Papsuev O, Rybakowski JK, Sachs G, Üçok A, Wojciak P, Galderisi S. Mucci A, et al. Among authors: galderisi s. Eur Neuropsychopharmacol. 2019 Aug;29(8):947-959. doi: 10.1016/j.euroneuro.2019.05.006. Epub 2019 Jun 27. Eur Neuropsychopharmacol. 2019. PMID: 31255394 Free article.
Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies-PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice.
Tognin S, van Hell HH, Merritt K, Winter-van Rossum I, Bossong MG, Kempton MJ, Modinos G, Fusar-Poli P, Mechelli A, Dazzan P, Maat A, de Haan L, Crespo-Facorro B, Glenthøj B, Lawrie SM, McDonald C, Gruber O, van Amelsvoort T, Arango C, Kircher T, Nelson B, Galderisi S, Bressan R, Kwon JS, Weiser M, Mizrahi R, Sachs G, Maatz A, Kahn R, McGuire P; PSYSCAN Consortium. Tognin S, et al. Among authors: galderisi s. Schizophr Bull. 2020 Feb 26;46(2):432-441. doi: 10.1093/schbul/sbz067. Schizophr Bull. 2020. PMID: 31424555 Free PMC article.
Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention.
Fusar-Poli P, Salazar de Pablo G, Correll CU, Meyer-Lindenberg A, Millan MJ, Borgwardt S, Galderisi S, Bechdolf A, Pfennig A, Kessing LV, van Amelsvoort T, Nieman DH, Domschke K, Krebs MO, Koutsouleris N, McGuire P, Do KQ, Arango C. Fusar-Poli P, et al. Among authors: galderisi s. JAMA Psychiatry. 2020 Jul 1;77(7):755-765. doi: 10.1001/jamapsychiatry.2019.4779. JAMA Psychiatry. 2020. PMID: 32159746
Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning.
Bucci P, Mucci A, van Rossum IW, Aiello C, Arango C, Baandrup L, Buchanan RW, Dazzan P, Demjaha A, Díaz-Caneja CM, Giordano GM, Glenthøj BY, Leucht S, McGuire P, Rodriguez-Jimenez R, Vignapiano A, Kahn RS, Galderisi S. Bucci P, et al. Among authors: galderisi s. Eur Neuropsychopharmacol. 2020 May;34:76-86. doi: 10.1016/j.euroneuro.2020.03.010. Epub 2020 Apr 11. Eur Neuropsychopharmacol. 2020. PMID: 32291210 Clinical Trial.
Rasch analysis of the PANSS negative subscale and exploration of negative symptom trajectories in first-episode schizophrenia - data from the OPTiMiSE trial.
Baandrup L, Allerup P, Nielsen MØ, Bak N, Düring SW, Leucht S, Galderisi S, Mucci A, Bucci P, Arango C, Díaz-Caneja CM, Dazzan P, McGuire P, Demjaha A, Ebdrup BH, Kahn RS, Glenthøj BY. Baandrup L, et al. Among authors: galderisi s. Psychiatry Res. 2020 Jul;289:112970. doi: 10.1016/j.psychres.2020.112970. Epub 2020 Apr 18. Psychiatry Res. 2020. PMID: 32438207
271 results